FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792623786> ?p ?o ?g. }

• W2792623786 endingPage "13767" @default.
• W2792623786 startingPage "13758" @default.
• W2792623786 abstract "// Ming-Jenn Chen 1, 2, * , De-Wei Wu 3, * , Gao-Chang Wang 3 , Yao-Chen Wang 4, 6 , Chi-Yi Chen 5, 6 and Huei Lee 3 1 Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan, ROC 2 Department of Sports Management, College of Leisure and Recreation Management, Chia Nan University of Pharmacy and Science, Tainan, Taiwan, ROC 3 Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan, ROC 4 Department of Internal Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC 5 Department of Surgery, Chung Shan Medical University, Taichung, Taiwan, ROC 6 School of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC * These authors contributed equally to this work Correspondence to: Huei Lee, email: hl@tmu.edu.tw Keywords: Micro-630; Bcl-2; cisplatin; chemotherapy; NSCLC Received: July 26, 2017      Accepted: February 03, 2018      Published: February 09, 2018 ABSTRACT MicroRNA-630 (miR-630) plays dual roles in tumor progression in various human cancers. However, the role of miR-630 in chemoresistance and prognosis in non-small cell lung cancer (NSCLC) remains to be elucidated. This retrospective study enrolled 114 surgically resected patients with NSCLC who experienced tumor relapse and underwent cisplatin-based chemotherapy. The aim was to examine the possible association between miR-630 (and its targeting of Bcl-2 expression) and the response to cisplatin-based chemotherapy. Patients with tumors expressing low miR-630, high Bcl-2, and a combination of both were more likely than their counterparts to show unfavorable responses to cisplatin-based chemotherapy. Kaplan–Meier and Cox regression analysis indicated that low miR-630, high Bcl-2, and a combination of both may independently predict poor overall survival and short relapse-free survival in patients with NSCLC. Six types of NSCLC cells were collected to determine the inhibitory concentration of cisplatin yielding 50% viability (IC50) by the MTT assay. The IC50 value for cisplatin was negatively correlated with miR-630 expression levels among these cell types, except for A549 cells. Mechanistically, low miR-630 expression conferred cisplatin resistance and colony formation by de-targeting Bcl-2 in NSCLC cells. We therefore suggest that low miR-630, high Bcl-2, and a combination of both may potentially predict an unfavorable chemotherapeutic response and poor outcome in patients with NSCLC." @default.
• W2792623786 created "2018-03-29" @default.
• W2792623786 creator A5015211581 @default.
• W2792623786 creator A5016834631 @default.
• W2792623786 creator A5039001895 @default.
• W2792623786 creator A5040045799 @default.
• W2792623786 creator A5043664053 @default.
• W2792623786 creator A5081349873 @default.
• W2792623786 date "2018-02-09" @default.
• W2792623786 modified "2023-10-15" @default.
• W2792623786 title "MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2" @default.
• W2792623786 cites W1565126135 @default.
• W2792623786 cites W1665688588 @default.
• W2792623786 cites W1989483296 @default.
• W2792623786 cites W2040555453 @default.
• W2792623786 cites W2066027374 @default.
• W2792623786 cites W2066137841 @default.
• W2792623786 cites W2069203180 @default.
• W2792623786 cites W2071110291 @default.
• W2792623786 cites W2085996951 @default.
• W2792623786 cites W2127289105 @default.
• W2792623786 cites W2134021858 @default.
• W2792623786 cites W2152694160 @default.
• W2792623786 cites W2160004726 @default.
• W2792623786 cites W2177629271 @default.
• W2792623786 cites W2396583006 @default.
• W2792623786 cites W2400361802 @default.
• W2792623786 cites W2469307120 @default.
• W2792623786 cites W2502310207 @default.
• W2792623786 cites W2509218126 @default.
• W2792623786 doi "https://doi.org/10.18632/oncotarget.24474" @default.
• W2792623786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5862613" @default.
• W2792623786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29568392" @default.
• W2792623786 hasPublicationYear "2018" @default.
• W2792623786 type Work @default.
• W2792623786 sameAs 2792623786 @default.
• W2792623786 citedByCount "22" @default.
• W2792623786 countsByYear W27926237862018 @default.
• W2792623786 countsByYear W27926237862019 @default.
• W2792623786 countsByYear W27926237862020 @default.
• W2792623786 countsByYear W27926237862021 @default.
• W2792623786 countsByYear W27926237862022 @default.
• W2792623786 countsByYear W27926237862023 @default.
• W2792623786 crossrefType "journal-article" @default.
• W2792623786 hasAuthorship W2792623786A5015211581 @default.
• W2792623786 hasAuthorship W2792623786A5016834631 @default.
• W2792623786 hasAuthorship W2792623786A5039001895 @default.
• W2792623786 hasAuthorship W2792623786A5040045799 @default.
• W2792623786 hasAuthorship W2792623786A5043664053 @default.
• W2792623786 hasAuthorship W2792623786A5081349873 @default.
• W2792623786 hasBestOaLocation W27926237861 @default.
• W2792623786 hasConcept C121608353 @default.
• W2792623786 hasConcept C126322002 @default.
• W2792623786 hasConcept C143998085 @default.
• W2792623786 hasConcept C2776256026 @default.
• W2792623786 hasConcept C2776694085 @default.
• W2792623786 hasConcept C2778239845 @default.
• W2792623786 hasConcept C71924100 @default.
• W2792623786 hasConceptScore W2792623786C121608353 @default.
• W2792623786 hasConceptScore W2792623786C126322002 @default.
• W2792623786 hasConceptScore W2792623786C143998085 @default.
• W2792623786 hasConceptScore W2792623786C2776256026 @default.
• W2792623786 hasConceptScore W2792623786C2776694085 @default.
• W2792623786 hasConceptScore W2792623786C2778239845 @default.
• W2792623786 hasConceptScore W2792623786C71924100 @default.
• W2792623786 hasIssue "17" @default.
• W2792623786 hasLocation W27926237861 @default.
• W2792623786 hasLocation W27926237862 @default.
• W2792623786 hasLocation W27926237863 @default.
• W2792623786 hasLocation W27926237864 @default.
• W2792623786 hasOpenAccess W2792623786 @default.
• W2792623786 hasPrimaryLocation W27926237861 @default.
• W2792623786 hasRelatedWork W2032912323 @default.
• W2792623786 hasRelatedWork W2055244776 @default.
• W2792623786 hasRelatedWork W2100029565 @default.
• W2792623786 hasRelatedWork W2187491254 @default.
• W2792623786 hasRelatedWork W2348529436 @default.
• W2792623786 hasRelatedWork W2390152934 @default.
• W2792623786 hasRelatedWork W2413020017 @default.
• W2792623786 hasRelatedWork W2414573978 @default.
• W2792623786 hasRelatedWork W363598932 @default.
• W2792623786 hasRelatedWork W4206600817 @default.
• W2792623786 hasVolume "9" @default.
• W2792623786 isParatext "false" @default.
• W2792623786 isRetracted "false" @default.
• W2792623786 magId "2792623786" @default.
• W2792623786 workType "article" @default.